News and Announcements
The Agency Group (ASX: AU1) re-evaluates its acquisition opportunities
- Published April 25, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- The Agency Group Australia Ltd is an assembly of businesses responsible for providing services within the financial sector.
- The company aims to become a national success.
- Recently, the company has terminated a previous offer based on better acquisition opportunities being presented to them.
The Agency Group Australia Ltd is a collection of companies that provide services such as monetary broking, property amenities, community services, project organisation, project promotion, insurance, and monetary preparation. The company is based in Western Australia aims to become a national accomplishment. Thus, the agents of the company have transferred the majority of the sales to monetary broking and aims to increase its number of sales representatives locally and nationally. Furthermore, the company is backed by Finsure Group, an Australian finance brokerage that has recently become highly successful and popular.
The Agency Group Australia (ASX) has terminated their previous acquisition offer. This is due to the company being offered newer acquisition opportunities. The company requires time in order to process the options of the acquisitions made available to them. These acquisitions may offer the company a better footprint in the sales sector and allow the company to acquire a sturdy authority in functioning markets. As a result, the company aims to find the acquisition opportunity that will offer them the best strategy while still improving its agent figures and its contribution to the EBITDA. Hence, the company is in the process of discussing the acquisition prospects given to them in an attempt to replace the preceding arrangements.
About The Agency (ASX: AU1)
The Agency is disrupting the real-estate industry by being the first fully integrated real estate and financial services company. The Company uses property transactions and/or financing events to review and service a client’s complete finance and wealth requirements.
The Agency wishes to raise up to $2 million of additional equity capital via the issue of 100m shares at an issue price of $0.02 per share pursuant to a placement (“Placement”). The Company has the ability to accept oversubscriptions of an additional $1.0m.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
